CN108125232A - 预防与治疗泌尿系结石的补充剂及其制备方法和应用 - Google Patents
预防与治疗泌尿系结石的补充剂及其制备方法和应用 Download PDFInfo
- Publication number
- CN108125232A CN108125232A CN201711082968.3A CN201711082968A CN108125232A CN 108125232 A CN108125232 A CN 108125232A CN 201711082968 A CN201711082968 A CN 201711082968A CN 108125232 A CN108125232 A CN 108125232A
- Authority
- CN
- China
- Prior art keywords
- powder
- ion
- replenishers
- juice
- magnesium
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000002485 urinary effect Effects 0.000 title claims abstract description 15
- 239000004575 stone Substances 0.000 title claims abstract description 14
- 230000002265 prevention Effects 0.000 title claims abstract description 9
- 238000002360 preparation method Methods 0.000 title abstract description 11
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 claims abstract description 52
- JLVVSXFLKOJNIY-UHFFFAOYSA-N Magnesium ion Chemical compound [Mg+2] JLVVSXFLKOJNIY-UHFFFAOYSA-N 0.000 claims abstract description 28
- 229910001414 potassium ion Inorganic materials 0.000 claims abstract description 28
- NPYPAHLBTDXSSS-UHFFFAOYSA-N Potassium ion Chemical compound [K+] NPYPAHLBTDXSSS-UHFFFAOYSA-N 0.000 claims abstract description 27
- 229910001425 magnesium ion Inorganic materials 0.000 claims abstract description 27
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 claims abstract description 26
- 239000011726 vitamin B6 Substances 0.000 claims abstract description 26
- 235000019158 vitamin B6 Nutrition 0.000 claims abstract description 26
- 229940011671 vitamin b6 Drugs 0.000 claims abstract description 26
- 239000000843 powder Substances 0.000 claims description 50
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims description 24
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 claims description 21
- 239000000284 extract Substances 0.000 claims description 20
- 239000011777 magnesium Substances 0.000 claims description 18
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims description 17
- 239000003814 drug Substances 0.000 claims description 17
- 229910052749 magnesium Inorganic materials 0.000 claims description 17
- 229940079593 drug Drugs 0.000 claims description 15
- 235000005979 Citrus limon Nutrition 0.000 claims description 14
- 244000131522 Citrus pyriformis Species 0.000 claims description 14
- 238000000034 method Methods 0.000 claims description 14
- 235000013399 edible fruits Nutrition 0.000 claims description 13
- 229920002752 Konjac Polymers 0.000 claims description 11
- 235000013305 food Nutrition 0.000 claims description 11
- 239000007788 liquid Substances 0.000 claims description 11
- 235000013361 beverage Nutrition 0.000 claims description 10
- 235000001674 Agaricus brunnescens Nutrition 0.000 claims description 8
- 239000007864 aqueous solution Substances 0.000 claims description 8
- 229930006000 Sucrose Natural products 0.000 claims description 7
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 7
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 7
- 239000002994 raw material Substances 0.000 claims description 7
- 239000007787 solid Substances 0.000 claims description 7
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 claims description 6
- 229920001817 Agar Polymers 0.000 claims description 6
- 240000000588 Hericium erinaceus Species 0.000 claims description 6
- 235000007328 Hericium erinaceus Nutrition 0.000 claims description 6
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 claims description 6
- 239000008272 agar Substances 0.000 claims description 6
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 claims description 6
- 235000013312 flour Nutrition 0.000 claims description 6
- 235000015205 orange juice Nutrition 0.000 claims description 6
- 239000005720 sucrose Substances 0.000 claims description 6
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 claims description 5
- 241000222532 Agrocybe Species 0.000 claims description 5
- 241000206575 Chondrus crispus Species 0.000 claims description 5
- 229930091371 Fructose Natural products 0.000 claims description 5
- 239000005715 Fructose Substances 0.000 claims description 5
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 claims description 5
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 5
- 244000060234 Gmelina philippensis Species 0.000 claims description 5
- 241000577951 Hydnum Species 0.000 claims description 5
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 claims description 5
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 claims description 5
- 238000004806 packaging method and process Methods 0.000 claims description 5
- 230000001954 sterilising effect Effects 0.000 claims description 5
- 229920001285 xanthan gum Polymers 0.000 claims description 5
- 235000007516 Chrysanthemum Nutrition 0.000 claims description 4
- 244000189548 Chrysanthemum x morifolium Species 0.000 claims description 4
- 108010035532 Collagen Proteins 0.000 claims description 4
- 102000008186 Collagen Human genes 0.000 claims description 4
- 108010010803 Gelatin Proteins 0.000 claims description 4
- 239000005913 Maltodextrin Substances 0.000 claims description 4
- 229920002774 Maltodextrin Polymers 0.000 claims description 4
- 229920001436 collagen Polymers 0.000 claims description 4
- 239000008273 gelatin Substances 0.000 claims description 4
- 229920000159 gelatin Polymers 0.000 claims description 4
- 235000019322 gelatine Nutrition 0.000 claims description 4
- 235000011852 gelatine desserts Nutrition 0.000 claims description 4
- 229940035034 maltodextrin Drugs 0.000 claims description 4
- 238000007789 sealing Methods 0.000 claims description 4
- 235000013311 vegetables Nutrition 0.000 claims description 4
- 244000144725 Amygdalus communis Species 0.000 claims description 3
- 235000011437 Amygdalus communis Nutrition 0.000 claims description 3
- 235000020224 almond Nutrition 0.000 claims description 3
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 3
- 239000008103 glucose Substances 0.000 claims description 3
- 235000020238 sunflower seed Nutrition 0.000 claims description 3
- 235000008733 Citrus aurantifolia Nutrition 0.000 claims description 2
- 241000196324 Embryophyta Species 0.000 claims description 2
- 240000007049 Juglans regia Species 0.000 claims description 2
- 235000009496 Juglans regia Nutrition 0.000 claims description 2
- 235000011941 Tilia x europaea Nutrition 0.000 claims description 2
- 239000007910 chewable tablet Substances 0.000 claims description 2
- 235000009508 confectionery Nutrition 0.000 claims description 2
- 235000013373 food additive Nutrition 0.000 claims description 2
- 239000002778 food additive Substances 0.000 claims description 2
- 235000019674 grape juice Nutrition 0.000 claims description 2
- 235000013944 peach juice Nutrition 0.000 claims description 2
- 235000013997 pineapple juice Nutrition 0.000 claims description 2
- 235000020234 walnut Nutrition 0.000 claims description 2
- 102000009027 Albumins Human genes 0.000 claims 1
- 108010088751 Albumins Proteins 0.000 claims 1
- 244000269722 Thea sinensis Species 0.000 claims 1
- 210000000481 breast Anatomy 0.000 claims 1
- 239000003292 glue Substances 0.000 claims 1
- 235000013402 health food Nutrition 0.000 claims 1
- 239000002304 perfume Substances 0.000 claims 1
- 235000013599 spices Nutrition 0.000 claims 1
- -1 citrate ions Chemical class 0.000 abstract description 9
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 118
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 55
- 210000002700 urine Anatomy 0.000 description 46
- 239000000047 product Substances 0.000 description 44
- 235000015165 citric acid Nutrition 0.000 description 40
- 239000000463 material Substances 0.000 description 16
- 235000006408 oxalic acid Nutrition 0.000 description 16
- QXDMQSPYEZFLGF-UHFFFAOYSA-L calcium oxalate Chemical compound [Ca+2].[O-]C(=O)C([O-])=O QXDMQSPYEZFLGF-UHFFFAOYSA-L 0.000 description 15
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 11
- 201000010099 disease Diseases 0.000 description 10
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 10
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 9
- 229960003975 potassium Drugs 0.000 description 9
- 239000011591 potassium Substances 0.000 description 9
- 239000001508 potassium citrate Substances 0.000 description 9
- 229960002635 potassium citrate Drugs 0.000 description 9
- QEEAPRPFLLJWCF-UHFFFAOYSA-K potassium citrate (anhydrous) Chemical compound [K+].[K+].[K+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O QEEAPRPFLLJWCF-UHFFFAOYSA-K 0.000 description 9
- 235000011082 potassium citrates Nutrition 0.000 description 9
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 8
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 8
- 229910001424 calcium ion Inorganic materials 0.000 description 8
- 238000001514 detection method Methods 0.000 description 8
- 230000029142 excretion Effects 0.000 description 8
- 238000012216 screening Methods 0.000 description 8
- 206010067484 Adverse reaction Diseases 0.000 description 7
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 7
- 230000006838 adverse reaction Effects 0.000 description 7
- 239000011575 calcium Substances 0.000 description 7
- 235000019629 palatability Nutrition 0.000 description 7
- 229910052700 potassium Inorganic materials 0.000 description 7
- 230000000638 stimulation Effects 0.000 description 7
- 238000012360 testing method Methods 0.000 description 7
- 229940116269 uric acid Drugs 0.000 description 7
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 6
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 6
- 229910052791 calcium Inorganic materials 0.000 description 6
- 235000013339 cereals Nutrition 0.000 description 6
- 239000013078 crystal Substances 0.000 description 6
- 210000001035 gastrointestinal tract Anatomy 0.000 description 6
- YPSNMKHPDJVGEX-UHFFFAOYSA-L potassium;sodium;3-carboxy-3-hydroxypentanedioate Chemical compound [Na+].[K+].OC(=O)CC(O)(C([O-])=O)CC([O-])=O YPSNMKHPDJVGEX-UHFFFAOYSA-L 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 206010070840 Gastrointestinal tract irritation Diseases 0.000 description 5
- 235000010419 agar Nutrition 0.000 description 5
- 238000013329 compounding Methods 0.000 description 5
- 238000011156 evaluation Methods 0.000 description 5
- HHLFWLYXYJOTON-UHFFFAOYSA-N glyoxylic acid Chemical compound OC(=O)C=O HHLFWLYXYJOTON-UHFFFAOYSA-N 0.000 description 5
- 230000036541 health Effects 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- LUEWUZLMQUOBSB-FSKGGBMCSA-N (2s,3s,4s,5s,6r)-2-[(2r,3s,4r,5r,6s)-6-[(2r,3s,4r,5s,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5s,6r)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@@H](O[C@@H]2[C@H](O[C@@H](OC3[C@H](O[C@@H](O)[C@@H](O)[C@H]3O)CO)[C@@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O LUEWUZLMQUOBSB-FSKGGBMCSA-N 0.000 description 4
- 244000247812 Amorphophallus rivieri Species 0.000 description 4
- 235000001206 Amorphophallus rivieri Nutrition 0.000 description 4
- 240000004307 Citrus medica Species 0.000 description 4
- 229920002581 Glucomannan Polymers 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 239000003513 alkali Substances 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 229940046240 glucomannan Drugs 0.000 description 4
- 235000021552 granulated sugar Nutrition 0.000 description 4
- 150000002500 ions Chemical class 0.000 description 4
- 239000000252 konjac Substances 0.000 description 4
- 235000010485 konjac Nutrition 0.000 description 4
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 4
- 235000019341 magnesium sulphate Nutrition 0.000 description 4
- 239000002245 particle Substances 0.000 description 4
- 230000002829 reductive effect Effects 0.000 description 4
- 239000002002 slurry Substances 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical group CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- 239000004471 Glycine Substances 0.000 description 3
- 108090000942 Lactalbumin Proteins 0.000 description 3
- 102000004407 Lactalbumin Human genes 0.000 description 3
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
- 208000009911 Urinary Calculi Diseases 0.000 description 3
- 230000009102 absorption Effects 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 239000001506 calcium phosphate Substances 0.000 description 3
- 229910000389 calcium phosphate Inorganic materials 0.000 description 3
- 235000011010 calcium phosphates Nutrition 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 235000012055 fruits and vegetables Nutrition 0.000 description 3
- 230000002496 gastric effect Effects 0.000 description 3
- 229940014259 gelatin Drugs 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 210000003734 kidney Anatomy 0.000 description 3
- 230000004060 metabolic process Effects 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 239000012071 phase Substances 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 210000000697 sensory organ Anatomy 0.000 description 3
- 239000011122 softwood Substances 0.000 description 3
- 239000007939 sustained release tablet Substances 0.000 description 3
- 210000001779 taste bud Anatomy 0.000 description 3
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 3
- 208000004998 Abdominal Pain Diseases 0.000 description 2
- 206010000087 Abdominal pain upper Diseases 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 2
- 108010064733 Angiotensins Proteins 0.000 description 2
- 102000015427 Angiotensins Human genes 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 241000207199 Citrus Species 0.000 description 2
- 244000000626 Daucus carota Species 0.000 description 2
- 235000002767 Daucus carota Nutrition 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 244000068988 Glycine max Species 0.000 description 2
- 235000010469 Glycine max Nutrition 0.000 description 2
- 208000000913 Kidney Calculi Diseases 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- 235000011430 Malus pumila Nutrition 0.000 description 2
- 235000015103 Malus silvestris Nutrition 0.000 description 2
- 229910017677 NH4H2 Inorganic materials 0.000 description 2
- 206010029148 Nephrolithiasis Diseases 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- DLRVVLDZNNYCBX-UHFFFAOYSA-N Polydextrose Polymers OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(O)O1 DLRVVLDZNNYCBX-UHFFFAOYSA-N 0.000 description 2
- 240000005809 Prunus persica Species 0.000 description 2
- 235000006040 Prunus persica var persica Nutrition 0.000 description 2
- 244000294611 Punica granatum Species 0.000 description 2
- 235000014360 Punica granatum Nutrition 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 208000003056 Vitamin B6 deficiency Diseases 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- 239000002416 angiotensin derivative Substances 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 235000020971 citrus fruits Nutrition 0.000 description 2
- 238000002425 crystallisation Methods 0.000 description 2
- 230000008025 crystallization Effects 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 239000003651 drinking water Substances 0.000 description 2
- 235000020188 drinking water Nutrition 0.000 description 2
- 239000007938 effervescent tablet Substances 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 238000000705 flame atomic absorption spectrometry Methods 0.000 description 2
- 238000005469 granulation Methods 0.000 description 2
- 230000003179 granulation Effects 0.000 description 2
- 230000007794 irritation Effects 0.000 description 2
- 239000007791 liquid phase Substances 0.000 description 2
- 238000011068 loading method Methods 0.000 description 2
- 238000005374 membrane filtration Methods 0.000 description 2
- 208000030159 metabolic disease Diseases 0.000 description 2
- SBNFWQZLDJGRLK-UHFFFAOYSA-N phenothrin Chemical compound CC1(C)C(C=C(C)C)C1C(=O)OCC1=CC=CC(OC=2C=CC=CC=2)=C1 SBNFWQZLDJGRLK-UHFFFAOYSA-N 0.000 description 2
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 2
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 2
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 2
- 239000001103 potassium chloride Substances 0.000 description 2
- 235000011164 potassium chloride Nutrition 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 150000003180 prostaglandins Chemical class 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 230000001953 sensory effect Effects 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- 230000001502 supplementing effect Effects 0.000 description 2
- 239000003643 water by type Substances 0.000 description 2
- XKJVEVRQMLKSMO-SSDOTTSWSA-N (2R)-homocitric acid Chemical compound OC(=O)CC[C@](O)(C(O)=O)CC(O)=O XKJVEVRQMLKSMO-SSDOTTSWSA-N 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- GJQWCDSAOUMKSE-STHAYSLISA-N 2,3-diketogulonic acid Chemical compound OC[C@H](O)[C@@H](O)C(=O)C(=O)C(O)=O GJQWCDSAOUMKSE-STHAYSLISA-N 0.000 description 1
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 description 1
- 208000019932 Aciduria Diseases 0.000 description 1
- 244000045069 Agrocybe aegerita Species 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- 241000190633 Cordyceps Species 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 1
- 206010016330 Feeling drunk Diseases 0.000 description 1
- 235000019733 Fish meal Nutrition 0.000 description 1
- 241000628997 Flos Species 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- MVORZMQFXBLMHM-QWRGUYRKSA-N Gly-His-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)CN)CC1=CN=CN1 MVORZMQFXBLMHM-QWRGUYRKSA-N 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- 201000002980 Hyperparathyroidism Diseases 0.000 description 1
- 208000029663 Hypophosphatemia Diseases 0.000 description 1
- 235000002710 Ilex cornuta Nutrition 0.000 description 1
- 241001310146 Ilex cornuta Species 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- LEVWYRKDKASIDU-IMJSIDKUSA-N L-cystine Chemical compound [O-]C(=O)[C@@H]([NH3+])CSSC[C@H]([NH3+])C([O-])=O LEVWYRKDKASIDU-IMJSIDKUSA-N 0.000 description 1
- 229920000161 Locust bean gum Polymers 0.000 description 1
- 206010027423 Metabolic alkalosis Diseases 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- 240000008790 Musa x paradisiaca Species 0.000 description 1
- 235000018290 Musa x paradisiaca Nutrition 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 235000010326 Osmanthus heterophyllus Nutrition 0.000 description 1
- 108010058846 Ovalbumin Proteins 0.000 description 1
- 229920001100 Polydextrose Polymers 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 244000197580 Poria cocos Species 0.000 description 1
- 235000008599 Poria cocos Nutrition 0.000 description 1
- 241000220317 Rosa Species 0.000 description 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
- FKNQFGJONOIPTF-UHFFFAOYSA-N Sodium cation Chemical compound [Na+] FKNQFGJONOIPTF-UHFFFAOYSA-N 0.000 description 1
- 239000004383 Steviol glycoside Substances 0.000 description 1
- 239000004376 Sucralose Substances 0.000 description 1
- 102000003929 Transaminases Human genes 0.000 description 1
- 108090000340 Transaminases Proteins 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 235000009754 Vitis X bourquina Nutrition 0.000 description 1
- 235000012333 Vitis X labruscana Nutrition 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 239000005862 Whey Substances 0.000 description 1
- 102000007544 Whey Proteins Human genes 0.000 description 1
- 108010046377 Whey Proteins Proteins 0.000 description 1
- 229960000583 acetic acid Drugs 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 229940023476 agar Drugs 0.000 description 1
- 238000007605 air drying Methods 0.000 description 1
- MXZRMHIULZDAKC-UHFFFAOYSA-L ammonium magnesium phosphate Chemical compound [NH4+].[Mg+2].[O-]P([O-])([O-])=O MXZRMHIULZDAKC-UHFFFAOYSA-L 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 238000010923 batch production Methods 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 230000019522 cellular metabolic process Effects 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 229960004106 citric acid Drugs 0.000 description 1
- 238000009535 clinical urine test Methods 0.000 description 1
- 230000000536 complexating effect Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 229960003067 cystine Drugs 0.000 description 1
- 229940067866 dandelion extract Drugs 0.000 description 1
- 235000020691 dandelion extract Nutrition 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- IRXRGVFLQOSHOH-UHFFFAOYSA-L dipotassium;oxalate Chemical compound [K+].[K+].[O-]C(=O)C([O-])=O IRXRGVFLQOSHOH-UHFFFAOYSA-L 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- 235000014103 egg white Nutrition 0.000 description 1
- 210000000969 egg white Anatomy 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 238000010812 external standard method Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 239000004467 fishmeal Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 239000012362 glacial acetic acid Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 108010038983 glycyl-histidyl-lysine Proteins 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 238000000703 high-speed centrifugation Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 235000010420 locust bean gum Nutrition 0.000 description 1
- 239000000711 locust bean gum Substances 0.000 description 1
- 229960003511 macrogol Drugs 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- 235000011147 magnesium chloride Nutrition 0.000 description 1
- 159000000003 magnesium salts Chemical class 0.000 description 1
- 229960003390 magnesium sulfate Drugs 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- OKKJLVBELUTLKV-UHFFFAOYSA-N methanol Substances OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 238000000120 microwave digestion Methods 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 229940092253 ovalbumin Drugs 0.000 description 1
- 150000003891 oxalate salts Chemical class 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 229940094443 oxytocics prostaglandins Drugs 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- JKCNXKXYMRTCQZ-UHFFFAOYSA-N pentane-1-sulfonic acid;sodium Chemical compound [Na].CCCCCS(O)(=O)=O JKCNXKXYMRTCQZ-UHFFFAOYSA-N 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 239000001259 polydextrose Substances 0.000 description 1
- 235000013856 polydextrose Nutrition 0.000 description 1
- 229940035035 polydextrose Drugs 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 230000009103 reabsorption Effects 0.000 description 1
- 230000000306 recurrent effect Effects 0.000 description 1
- 239000013558 reference substance Substances 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- PPASLZSBLFJQEF-RKJRWTFHSA-M sodium ascorbate Substances [Na+].OC[C@@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RKJRWTFHSA-M 0.000 description 1
- 235000010378 sodium ascorbate Nutrition 0.000 description 1
- 229960005055 sodium ascorbate Drugs 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 229910001415 sodium ion Inorganic materials 0.000 description 1
- PPASLZSBLFJQEF-RXSVEWSESA-M sodium-L-ascorbate Chemical compound [Na+].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RXSVEWSESA-M 0.000 description 1
- 235000019411 steviol glycoside Nutrition 0.000 description 1
- 229930182488 steviol glycoside Natural products 0.000 description 1
- 150000008144 steviol glycosides Chemical class 0.000 description 1
- 235000019202 steviosides Nutrition 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- BAQAVOSOZGMPRM-QBMZZYIRSA-N sucralose Chemical compound O[C@@H]1[C@@H](O)[C@@H](Cl)[C@@H](CO)O[C@@H]1O[C@@]1(CCl)[C@@H](O)[C@H](O)[C@@H](CCl)O1 BAQAVOSOZGMPRM-QBMZZYIRSA-N 0.000 description 1
- 235000019408 sucralose Nutrition 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000001845 taraxacum officinale leaf extract Substances 0.000 description 1
- 235000012976 tarts Nutrition 0.000 description 1
- 239000012085 test solution Substances 0.000 description 1
- 210000005239 tubule Anatomy 0.000 description 1
- 230000000450 urinary calcium excretion Effects 0.000 description 1
- 208000014001 urinary system disease Diseases 0.000 description 1
- 230000016776 visual perception Effects 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
- A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
- A23G3/36—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds
- A23G3/364—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
- A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
- A23G3/36—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds
- A23G3/42—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds characterised by the carbohydrates used, e.g. polysaccharides
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
- A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
- A23G3/36—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds
- A23G3/44—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds containing peptides or proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
- A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
- A23G3/36—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds
- A23G3/48—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds containing plants or parts thereof, e.g. fruits, seeds, extracts
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L19/00—Products from fruits or vegetables; Preparation or treatment thereof
- A23L19/01—Instant products; Powders; Flakes; Granules
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/02—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation containing fruit or vegetable juices
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/385—Concentrates of non-alcoholic beverages
- A23L2/39—Dry compositions
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/40—Effervescence-generating compositions
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L25/00—Food consisting mainly of nutmeat or seeds; Preparation or treatment thereof
- A23L25/30—Mashed or comminuted products, e.g. pulp, pastes, meal, powders; Products made therefrom, e.g. blocks, flakes, snacks; Liquid or semi-liquid products
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Nutrition Science (AREA)
- Inorganic Chemistry (AREA)
- Mycology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Botany (AREA)
- Molecular Biology (AREA)
- Medicinal Preparation (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
本发明提供一种预防与治疗泌尿系结石的补充剂,含有柠檬酸离子,镁离子,钾离子及维生素B6。本发明还提供上述补充剂的制备方法和应用。
Description
技术领域
本发明涉及预防与治疗泌尿系结石的补充剂及其制备方法和应用。
背景技术
泌尿系结石疾病是一种全球范围内的重大健康疾病,发病率在5-10%,我国局部地区的发病率10-20%,泌尿系结石的常见成分为草酸钙,磷酸钙,尿酸,磷酸镁铵,胱氨酸等成分类型组成。
草酸钙结石在泌尿系结石患者中的占比最高,达到80%以上。尿液中的草酸来源有两个,一种是人体通过食源性吸收的草酸占尿草酸总量的10-70%不等,另一种是人体肝脏代谢产生的草酸,绝大部分的草酸通过尿液排泄。食源性吸收的草酸和人体代谢的草酸经血液循环进入肾脏,肾小管的重吸收功能,使绝大部分的水分及营养成分被重新吸收,导致草酸被浓缩10倍以上,草酸与尿液中的钙离子过饱和析出为草酸钙晶体。尿液中的镁离子和枸橼酸 (也称柠檬酸)离子有助于抑制过饱和的草酸钙析出为草酸钙晶体。枸橼酸钾可抑制钙离子的排泄,降低尿液中的钙离子浓度,抑制草酸钙晶体的形成。钾离子维持的碱负荷可以通过影响肾枸橼酸盐廓清和提高尿pH而使尿枸橼酸盐排泄增加。
多数含草酸钙肾结石的患者除了尿草酸含量高外,通常还会伴随着低枸橼酸尿症和低尿镁症。因此,提高尿枸橼酸和尿镁浓度,降低尿钙浓度,均有助于降低草酸钙肾结石的发病率。
24h尿枸橼酸排泄量小于320mg被称为低枸橼酸尿症。研究发现,泌尿系结石患者中高达70%的人伴随有尿枸橼酸排泄量异常,具体表现为排泄量明显下降,而尿液中枸橼酸根离子可以与尿液中的钙离子形成络合稳定态,从而降低钙离子与草酸根离子形成难溶的草酸钙晶体,析出为结石的风险。枸橼酸抑制结石形成的机制在于:(1)细胞中的枸橼酸代谢可以产生碳酸氢根离子,提高尿液pH值。(2)枸橼酸可以与钙离子形成络合物,减少尿液中的游离钙离子(约20%),避免草酸钙的过饱和而析出结晶。(3)枸橼酸可以抑制草酸钙和磷酸钙的结晶。
低尿镁症(<72mg/d)属于泌尿系结石形成危险因素的代谢异常之一。临床统计数据显示,泌尿系结石患者的低尿镁症比例约为25-42%。有学者认为,低尿镁/钙值(Mg/Ca)较单独的低尿镁症生长结石的风险更大。造成低尿镁的原因:(1)血清镁浓度低;(2)肾小球滤过率低;(3)低尿量;(4)内分泌因素如甲状旁腺功能亢进;(5)低磷酸盐血症;(6)代谢性碱中毒。
维生素B6是体内草酸代谢异常增多的关键因子。体内草酸形成主要有两条途径:(1)维生素C经二酮古洛糖酸转化而来,(2)甘氨酸经乙醛酸途径生成。乙醛酸是草酸的前体物,在转氨酶的作用下转化为甘氨酸需要维生素B6 的参与。当维生素B6缺乏时,乙醛酸不能转化为甘氨酸,但能被氧化转化为草酸,致使草酸形成增多。在动物实验中发现维生素B6缺乏会出现下列代谢异常:(1)由糖转化为草酸的量增加数倍;(2)肠道对草酸盐的主动吸收增加;(3)尿液中的枸橼酸排出量减少;(4)肾素和血管紧张素分泌增加。血管紧张素会刺激肾脏合成前列腺素,前列腺素可增加肠道对钙的吸收。Murthy 等发现给复发性草酸钙结石患者服用10mg/天的维生素B6,可明显降低尿草酸的排泄量。提示部分草酸钙结石患者可能存在亚临床状态的维生素B6缺乏。
钾离子与枸橼酸同时服用时,有利于增加尿枸橼酸的排泄量,同时钾离子也可以与钙同时竞争草酸根,而草酸钾的溶解度远远大于草酸钙的溶解度,有利于降低草酸钙的浓度,防止草酸钙晶体析出。此外,钾离子还可以降低钙离子的排泄,降低尿钙水平,进而降低草酸钙结石风险。
尿酸结石是因为尿液中的尿酸晶体析出形成结石,尿酸在偏酸性的环境中溶解度较低,随着pH值的升高,尿酸的溶解度迅速上升。当尿pH由5.0升至6.0,尿酸的溶解度上升5倍,当尿液升至7.0时,尿酸的溶解度上升20倍。枸橼酸在体内代谢产生碳酸盐,可碱化尿液,升高尿液的酸碱度。从而使尿酸的溶解度上升,防止尿酸结石的形成,同时溶解已形成的尿酸结石。因此,本发明也适用于尿酸结石的防治。
虽然市场上已经有用枸橼酸钾或枸橼酸氢钾钠为主要成分的预防和维持治疗泌尿系结石的产品(枸橼酸氢钾钠颗粒,如友来特,逍遥柠等,及枸橼酸钾缓释片,如Urocit-K,杰士同等),但是仅靠枸橼酸盐的作用,治疗泌尿系草酸钙结石的效果欠佳,且大剂量的服用(每天10g)对患者来说,体验很差,且有诸多的副作用,如腹泻,恶心,胃及腹部疼痛等。临床统计数据报道,不良反应率高达10%,致使25%的服药人员不能坚持完整治疗疗程(Penniston KL, Urology.2007;70:856-860)。此外,枸橼酸氢钾钠产品中含有的钠离子,会增加尿钙排泄,不利于结石的治疗,且两类产品均不含有对结石形成有明显抑制作用镁离子,以及可减少体内草酸生成的维生素B6成分。此外,此类药品的口感坏,患者的依从性很差,生活质量也不好。病人不能心情愉快的接受治疗。枸橼酸氢钾钠药品服用后,会迅速吸收,导致尿液pH的显著上升,然而其维持时间却非常短,尿液pH及尿液中的枸橼酸处于剧烈波动状态,增加了因尿液pH过高患磷酸钙结石的风险,虽然药品配备了尿液测试试纸条,建议服药患者一天三次检测尿液pH,但是操作麻烦,尤其是对于上班族,非常不方便。枸橼酸钾缓释片通过缓释技术虽然避免了尿枸橼酸含量及尿pH的剧烈波动,但是其服药剂量却显著增加,患者依从性差。
如果补充枸橼酸的同时,补充镁离子及维生素B6,患者则需要服用至少3 种药物,体验非常差。
发明内容
针对现有技术手段的不足,本发明专利提供了一种复配的补充剂,该产品选用了富含天然柠檬酸的水果浓缩物(汁/浆或粉),柠檬酸,镁(离子) 盐,钾(离子)盐及维生素B6,调配成口感好,成分丰富,服用方便等诸多良好体验的补充剂产品。经过我们调配后的,除了口感显著好于枸橼酸氢钾钠颗粒(友来特)及枸橼酸钾(杰士同)药物外,效果测试过程中惊奇的发现该产品的副作用的发生概率明显小于两种枸橼酸药物(本发明产品不良反应率<5%)。究其原因,本产品中柠檬酸与钾盐及镁盐的配比,降低了单服用枸橼酸盐(如友来特或杰士同产品)对味蕾和胃肠道的刺激,同时添加的果蔬汁及其他辅料,可以缓和柠檬酸盐对胃肠道的刺激,从而降低了不良反应率。此外,本专利推荐的产品服用策略(少量多次),也减缓了柠檬酸盐对胃肠道的刺激。本发明产品为结石患者在工作间隙,下午茶时间等,从容的饮用上一杯,既能补充所需要的电解质离子,又没有病人服药的感觉。少量多次的设计,避免了尿液枸橼酸及尿液pH的剧烈波动。
本发明提供了一种复配的补充剂,含有柠檬酸根离子、镁离子和钾离子,其在pH值3.0-5.0的水溶液状态下,摩尔质量比为,柠檬酸根离子:(钾离子+镁离子)=1:2.4-2:1。
优选的,钾离子与镁离子的摩尔质量比为,钾离子:镁离子=1:1-15:1。
优选的,补充剂还含有维生素B6,其在pH值3.0-5.0的水溶液状态下,按摩尔质量比计,柠檬酸根离子:钾离子:镁离子:维生素 B6=1:1.2:1.2:0.00005-2:0.9375:0.0625:0.02。
优选的,所述补充剂还含有维生素B6,其在pH值3.0-5.0的水溶液状态下,按摩尔质量比计,柠檬酸根离子:钾离子:镁离子:维生素 B6=1:1.36:0.15:0.0001。
优选的,柠檬酸根离子和镁离子,钾离子来自于富含柠檬酸根离子,镁离子,钾离子的果蔬汁或粉和/或食品添加剂。
更优选的,富含柠檬酸根离子的果蔬汁或粉,包括青梅汁或粉,乌梅汁或粉,柠檬汁或粉,青柠汁或粉,橙汁或粉,菠萝汁或粉等;富含镁离子及钾离子的果蔬汁或粉,包括核桃粉,杏仁粉,葵花籽粉,香蕉粉,葡萄汁或粉,橘子汁或粉,桃子汁或粉等。
优选的,配方中含有提升适口性或减缓胃肠道刺激的辅料,具体包含魔芋粉,乳清蛋白,葡萄糖,蔗糖,果糖,麦芽糖,海藻糖,麦芽糊精,卡拉胶,黄原胶,琼脂,明胶,魔芋胶,水果酵素,蔬菜酵素,果蔬酵素,胶原蛋白肽,菊花提取物,猴头菇粉,猴头菇提取物,茶树菇提取物,茯苓多糖等辅料中的一种或多种。
配方中含有提升适口性或减缓胃肠道刺激的辅料,更优选为魔芋粉,乳清蛋白,葡萄糖,蔗糖,果蔬酵素,猴头菇粉,猴头菇提取物,茶树菇提取物,茯苓多糖。
本发明提供的复配补充剂形式包括液体饮料,口服液,固体饮料,泡腾片,咀嚼片及压片糖果等。
优选的,产品形式为普通食品,保健品,特殊医学用途配方食品及药品,用于补充尿液中的枸橼酸,镁离子,从而防治泌尿系结石的发病。
本发明提供了复配补充剂的制备方法,其特征在于,将产品物料按配方比例精确称取,按照不同类型产品的工艺流程进行生产,灭菌,包装至密封的包装中。
本发明的其它特征和优点将在随后的说明书中阐述,并且,部分地从说明书中变得显而易见,或者通过实施本发明而了解。本发明的目的和其他优点可通过在所写的说明书、权利要求书中所特别指出的结构来实现和获得。
具体实施方式
为了说明本发明所述的技术方案,下面通过具体实施例来进行说明。
实施例1:富含柠檬酸,钾或镁离子的果蔬种类筛选
根据大众最喜爱和常见的水果统计资料,挑选了新鲜的柠檬,青柠,橙汁,柑橘,苹果,青梅,胡萝卜等20余种水果。经切碎,匀浆,过滤后,得到鲜榨果汁(浆),应用HPLC的方法测定测定柠檬酸含量。具体操作步骤如下: (1)果汁样品经15000g高速离心去除大颗粒物质,经0.45μm滤膜过滤后上样10μL;(2)选用色谱柱:C18(4.6×250mm,5μm);流动相:0.8%NH4H2PO4水溶液;流速:0.6ml/min;检测波长:214nm;柱温:25℃。经测定,高柠檬酸含量的水果的测试结果如表1所示。样品经微波消解处理后,应用原子吸收法测定钾或镁离子的含量,具体结果如表2所示。
表.1果蔬中的柠檬酸含量
水果 | 柠檬酸含量(%) |
柠檬 | 5.2 |
青柠 | 4.6 |
橙子 | 1.1 |
柑橘 | 0.9 |
葡萄 | 2.6 |
青梅 | 4.2 |
表2果蔬中的钾离子,镁离子含量
种类 | 钾(mg/100g) | 镁(mg/100g) |
核桃 | 280 | |
杏仁 | 245 | |
葵花籽 | 257 | |
香蕉 | 243 | |
橘子 | 149 | |
桃子 | 171 | |
胡萝卜 | 210 | |
苹果 | 136 |
实施例2:柠檬酸,镁离子,钾离子及维生素B6的配比优化
柠檬酸离子与盐离子(镁离子,钾离子等)的配比显著影响着产品的感官体验和对胃肠道的刺激程度,盐离子会刺激胃肠粘膜导致胃痛,腹泻,腹痛等胃肠不适,柠檬酸的强酸性,剧烈刺激舌的味蕾,口感极差。维生素B6在偏碱性环境下不稳定,易被破坏。为了不同有效成分之间的兼容性以及提升口服的适口性,本发明人通过大量的配方实验设计与筛选,优化柠檬酸及盐离子的配比,适当降低酸度,同时控制盐浓度,可以增加适口性,辅料的加入,可以遮蔽部分酸味和咸味对味蕾的刺激,经过大量的筛选与评测试验,得出当pH 为3.0-5.0时,柠檬酸离子与盐离子(镁离子,钾离子等的总和)的摩尔质量比例为1:2.4-2:1时,配方的适口性最好,胃肠道刺激最小(见表3所示)。维生素B6的稳定性经紫外荧光-高效液相色谱仪检测,结果显示维生素B6在此pH值(pH 3.0-5.0)条件下是稳定的。
表3.不同柠檬酸与盐离子摩尔配比的水溶液对口感的影响
注:每个评测指标满分5分,分值越高,刺激性越强,适口性越差。
实施例3:降低胃肠道刺激的辅料筛选
本实施例阐述为了减少盐对胃肠道粘膜的刺激,所做的产品辅料的筛选。将实施例2中筛选到的柠檬酸盐最优配比用于本实施例辅料的筛选,筛选的材料有:(1)膳食纤维,包括聚葡萄糖,微晶纤维素,魔芋粉;(2)蛋白制品,包括乳清蛋白,卵清蛋白,大豆分离蛋白,全脂乳粉,鱼粉;(3)糖类,包括葡萄糖,蔗糖,果糖,麦芽糖,海藻糖,麦芽糊精,(4)食用果胶,包括卡拉胶,黄原胶,瓜尔豆胶、琼脂、明胶、海藻酸钠、刺槐豆胶和魔芋胶;(5) 酵素,包括水果酵素粉,蔬菜酵素粉,综合果蔬酵素粉;(6)肽粉,包括牛骨肽,胶原蛋白肽,大豆蛋白肽,鱼皮肽;(7)植物提取物,包括菊花提取物,玫瑰提取物,陈皮提取物,蒲公英提取物,桂花提取物,(8)食用菌粉及其提取物:包括猴头菇粉,猴头菇提取物,香菇粉及香菇提取物,虫草提取物,茯苓粉,茯苓多糖,茶树菇粉,茶树菇提取物,等等。
将上述辅料与实施例2中的酸盐组合进行高中低剂量的复配,并从视觉感官,味觉,胃肠道刺激感受等方面进行综合评定,筛选可作为产品辅料的种类,具体如下表4所示。结果显示,魔芋粉,蔗糖,果糖,麦芽糖,海藻糖,卡拉胶,黄原胶,琼脂,魔芋胶,猴头菇粉及猴头菇提取物均能明显的改善柠檬酸盐组合对胃肠道的刺激。此外,魔芋粉,乳清蛋白,葡萄糖,蔗糖,果糖,麦芽糖,海藻糖,麦芽糊精,卡拉胶,黄原胶,琼脂,明胶,魔芋胶,水果酵素,蔬菜酵素,果蔬酵素,胶原蛋白肽,菊花提取物,猴头菇提取物,茶树菇提取物,茯苓多糖均能较好的提升产品适口感官体验。表4.辅料筛选评价表
注:每个评测指标满分5分,分值越高,适口性越好。
实施例4:瓶装饮料产品的制备
本实施例以果汁饮料为例,阐述本发明产品的制备为液体饮料类别产品的配制流程。基于食品,保健品或药品类别,分别按相应的国家标准(或法规) 选用符合标准的优质原料:柠檬汁(浆),石榴汁(浆)、白砂糖、硫酸镁、柠檬酸、维生素B6、柠檬酸钾、抗坏血酸钠等,并进行原料质量检验。
按配方(表5)称取原料,用纯化水进行调配,抽取小样进行感官评定,符合要求后,进行放大批量生产。将调配好的物料经高温瞬时灭菌(UHT灭菌),灭菌结束后立刻灌装,热封口,冷却至室温,为成品。
表.5果汁饮料配方表(1kg)
配料 | 含量(g) |
白砂糖 | 90 |
柠檬酸 | 4.106 |
柠檬酸钾 | 1.224 |
柠檬汁 | 150 |
石榴汁 | 50 |
琼脂 | 1.5 |
氯化钠 | 2 |
硫酸镁 | 96mg |
维生素B6 | 52mg |
柠檬香精 | 1 |
水 | 700.022 |
实施例5:固体饮料产品的制备
本实施例以固体饮料为例,阐述本发明产品的制备为固体饮料类别产品的配制流程。基于食品,保健品或药品类别,分别按相应的国家标准(或法规) 选用符合标准的优质原料:柠檬果粉,维生素B6、甜味剂、硫酸镁、柠檬酸、柠檬酸钾等。各原料按配方(表6)进行混匀,过80目筛。在原料中加入纯净水(0.5-2%)制软材,软材的干湿度主要依靠感官判断捻之成团,压之即散。将制好的软材进行制粒,可避免粉状原料在加工时粉尘飞,即为湿法制粒。制粒完成后,将湿粒在盘中平铺,45℃下干燥箱中干燥3~4h左右,适时翻动,加快干燥速度。将整好的颗粒在紫外光下灭菌包装,密封避光保存。
表6.固体饮料配方表(1kg)
配料 | 含量(g) |
橙汁果粉 | 170 |
白砂糖 | 329.495 |
柠檬酸 | 105.5 |
柠檬酸钾 | 138 |
海藻糖 | 235.5 |
硫酸镁 | 18 |
维生素B6 | 0.021 |
三氯蔗糖 | 0.484 |
甜菊糖苷 | 1 |
AK-糖 | 2 |
实施例6:泡腾压片的制备
本实施例以泡腾压片为例,阐述本发明产品的制备为泡腾片类别产品的配制流程。基于食品,保健品或药品类别,分别按相应的国家标准(或法规)选用符合标准的优质原料:青梅粉,白沙糖,柠檬酸,碳酸氢钠,聚乙二醇6000, 聚乙烯吡咯烷酮(PVP)。将粉碎后的柠檬酸,碳酸氢钠分别与白砂糖,维生素B6,氯化镁,氯化钾,聚乙二醇,pvp等其他原料混合制粒为酸粒与碱粒。并分别放置于50℃下鼓风干燥至含水量<3%。将所制得的酸粒和碱粒混合均匀,送入压片机压片,及时包装,得成品。
表7.泡腾配方表(1kg)
实施例7产品功效指标的质量检测方法
本实施例简述了产品主要功效成分的检测方法。
柠檬酸含量的检测采用高效液相的方法。Waters高效液相色谱仪(四元梯度泵,配PDA-二极管阵列检测器),AkzoNobelKromasil C18色谱柱;流动相为乙腈-0.8%NH4H2PO4水溶液;流速:0.6ml/min;检测波长;214nm;柱温:25℃;进样量:10μL。以不同浓度的柠檬酸标准品制定柠檬酸的标准曲线。本发明产品经溶解,离心,0.45μm膜过滤等步骤进行预处理后上样,根据其柠檬酸的保留峰面积测定其柠檬酸含量。
维生素B6含量的检测参考《中国药典》的测定方法,选用高效液相方法进行检测。Waters高效液相色谱仪(四元梯度泵,配PDA-二极管阵列检测器), AkzoNobelKromasilC18色谱柱;以0.04%戊烷磺酸钠溶液(用冰醋酸调节pH 值至3.0)-甲醇(85:15)为流动相;检测波长为291nm。精密称取取本产品,加流动相溶解并定量稀释制成每1ml中约含0.1mg的溶液,作为供试品溶液,精密量取10μL注入液相色谱仪,记录色谱图;另取维生素B6对照品,同法测定。按外标法以峰面积计算,即得。
镁离子含量测定选用检测火焰原子吸收光谱法。具体操作方法参考国标GB5009.241-2017《食品安全国家标准食品中镁的测定》。
钾离子含量测定选用检测火焰原子吸收光谱法。具体操作方法参考国标GB5009.91-2017《食品安全国家标准食品中钾、钠的测定》。
实施例8产品口感及不良反应评定
本实施例以实施例5制备的固体饮料产品为例,进行产品口感及不良反应的评定。
募集了200人(年龄25~55岁)的志愿者,对优选产品配方进行感官评定。测试量为每日正常服用量,持续时间为7天,从酸甜度口感,感官,胃肠不适,等方面进行评价。结果如表8所示。
选择了市面上进行销售的友来特(枸橼酸氢钾钠颗粒),杰士同(枸橼酸钾缓释片)与本产品进行不良反应几率的对比。测试剂量为:友来特,10g/天,分4次;杰士同,60mEq/天,分3次;本产品,40g/天,分4次。结果如表9 所示。
表8.产品配方的感官评定
测试项目 | 非常喜欢 | 喜欢 | 一般 | 不喜欢 | 不能接受 |
口感(酸度) | 58 | 66 | 37 | 25 | 14 |
口感(甜度) | 64 | 70 | 24 | 27 | 15 |
口感(咸度) | 55 | 62 | 50 | 22 | 11 |
感官 | 46 | 62 | 65 | 22 | 5 |
表9.不良反应几率比较
实施例9:人体效果测试
募集患有低枸橼酸尿症和低尿镁症的门诊或住院泌尿系结石病人各10例,签订知情同意书,测试期间食用统一配制的工作餐。前3天为普通饮水,后3 天饮用实施例4方案制备的柠檬果汁饮料,饮水量均控制为2L。测试过程中收集24h尿液,分析尿液pH值,枸橼酸,尿镁,尿钾及尿钙含量。
结果显示,本发明配方可以有效补充尿枸橼酸,尿钾及尿镁含量,有助于缓解低枸橼酸尿症,低尿镁症,有助于泌尿系结石的防治。
表.10
显然,本领域的技术人员可以对本发明进行各种改动和变型而不脱离本发明的精神和范围。这样,倘若本发明的这些修改和变型属于本发明权利要求及其等同技术的范围之内,则本发明也意图包含这些改动和变型在内。
Claims (10)
1.一种预防与治疗泌尿系结石的补充剂,其特征在于,含有柠檬酸根离子、镁离子和钾离子,其在pH值3.0-5.0的水溶液状态下,摩尔质量比为,柠檬酸根离子:(钾离子+镁离子)=1:2.4-2:1。
2.权利要求1所述补充剂,其特征在于,钾离子与镁离子的摩尔质量比为,钾离子:镁离子=1:1-15:1。
3.权利要求1或2所述补充剂,其特征在于,所述补充剂还含有维生素B6,其在pH值3.0-5.0的水溶液状态下,按摩尔质量比计,柠檬酸根离子:钾离子:镁离子:维生素B6=1:1.2:1.2:0.00005-2:0.9375:0.0625:0.02。
4.权利要求3所述补充剂,其特征在于,其在pH值3.0-5.0的水溶液状态下,按摩尔质量比计,柠檬酸根离子:钾离子:镁离子:维生素B6=1:1.36:0.15:0.0001。
5.权利要求4所述补充剂,其特征在于,柠檬酸根离子、镁离子和/或钾离子来自于富含柠檬酸根离子、镁离子和/或钾离子的果蔬汁或粉和/或食品添加剂。
6.权利要求5所述补充剂,其特征在于,富含柠檬酸根离子的果蔬汁或粉为以下一种或几种的组合:青梅汁或粉、乌梅汁或粉、柠檬汁或粉、青柠汁或粉、橙汁或粉、菠萝汁或粉;富含镁离子及钾离子的果蔬汁或粉为以下一种或几种的组合:核桃粉、杏仁粉、葵花籽粉、香蕉粉、葡萄汁或粉、橘子汁或粉、桃子汁或粉。
7.权利要求6所述补充剂,其特征在于,配方中含有以下一种或其任意组合:魔芋粉、乳清蛋白、葡萄糖、蔗糖、果糖、麦芽糖、海藻糖、麦芽糊精、卡拉胶、黄原胶、琼脂、明胶、魔芋胶、水果酵素、蔬菜酵素、果蔬酵素、胶原蛋白肽、菊花提取物、猴头菇粉、猴头菇提取物、茶树菇粉、茶树菇提取物、茯苓多糖。
8.权利要求7所述补充剂,其特征在于,所述补充剂为液体饮料、口服液、固体饮料、泡腾片、咀嚼片或压片糖果。
9.制备权利1-8任一所述补充剂的方法,其特征在于,称取所述原料,按产品的工艺流程进行生产,灭菌,包装至密封的包装中。
10.权利要求1-8任一项所述补充剂在制备预防与治疗泌尿系结石的食品、保健食品、特殊医学用途配方食品或药物中的应用。
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710131895 | 2017-03-07 | ||
CN2017101318956 | 2017-03-07 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN108125232A true CN108125232A (zh) | 2018-06-08 |
Family
ID=62389146
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201711082968.3A Pending CN108125232A (zh) | 2017-03-07 | 2017-11-07 | 预防与治疗泌尿系结石的补充剂及其制备方法和应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108125232A (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111346192A (zh) * | 2020-04-09 | 2020-06-30 | 单鹏翼 | 一种治疗结石药物的配方及制备工艺 |
WO2022045903A1 (es) * | 2020-08-25 | 2022-03-03 | Cytorex International, Inc. | Método de elaboración de mezclas para lograr composiciones iónicas de uso terapéutico, que pueden ser administradas a seres humanos o animales por rutas orales, parenterales, íntraperitoneal, tópicas, óticas, nasales o mediante lavados, que resultan en el mejoramiento de enfermedades |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1322530A (zh) * | 2000-05-09 | 2001-11-21 | 詹炳炎 | 一种防治泌尿系结石的药物——尿石净 |
CN105209120A (zh) * | 2013-03-15 | 2015-12-30 | 纽约大学 | 含有柠檬酸盐的饮料 |
-
2017
- 2017-11-07 CN CN201711082968.3A patent/CN108125232A/zh active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1322530A (zh) * | 2000-05-09 | 2001-11-21 | 詹炳炎 | 一种防治泌尿系结石的药物——尿石净 |
CN105209120A (zh) * | 2013-03-15 | 2015-12-30 | 纽约大学 | 含有柠檬酸盐的饮料 |
Non-Patent Citations (2)
Title |
---|
何家扬: "《专家解读健康丛书 泌尿系结石咨询》", 31 July 2012, 上海交通大学出版社 * |
杨晓佩: "《快上手蔬果汁》", 31 August 2015, 重庆出版社 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111346192A (zh) * | 2020-04-09 | 2020-06-30 | 单鹏翼 | 一种治疗结石药物的配方及制备工艺 |
WO2022045903A1 (es) * | 2020-08-25 | 2022-03-03 | Cytorex International, Inc. | Método de elaboración de mezclas para lograr composiciones iónicas de uso terapéutico, que pueden ser administradas a seres humanos o animales por rutas orales, parenterales, íntraperitoneal, tópicas, óticas, nasales o mediante lavados, que resultan en el mejoramiento de enfermedades |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11096960B2 (en) | Mineral, nutritional, cosmetic, pharmaceutical, and agricultural compositions and methods for producing the same | |
US4738856A (en) | Beverage and method for making a beverage for the nutritional supplementation of calcium in humans | |
CA1306688C (en) | Iron mineral supplements | |
CN102552462B (zh) | 一种泡腾制剂及其制备方法和用途 | |
SK122593A3 (en) | Additives containing calcium and vitamin d | |
Gasińska et al. | Tea and coffee as the main sources of oxalate in diets of patients with kidney oxalate stones | |
CN104306617B (zh) | 含有玛咖和阿萨伊果的组合物及其制备方法和应用 | |
CN103751327A (zh) | 葡萄糖酸锌vc泡腾片 | |
EP2635264A1 (en) | Formulations comprising polyethylene glycol | |
CN103859253B (zh) | 一种大豆肽咀嚼片及其制备方法 | |
CN104664370A (zh) | 一种亚麻咀嚼片 | |
CN102716149A (zh) | 碳酸钙d3泡腾片及其制备方法 | |
US20150366906A1 (en) | Alkaline drink | |
US20200077678A1 (en) | Nutritionally Premium Cola Carbonated Soft Drink - Composition, Method of Preparation and Applications | |
CN108125232A (zh) | 预防与治疗泌尿系结石的补充剂及其制备方法和应用 | |
JPH0272843A (ja) | 糖アルコールを含有するミネラル補給剤 | |
US6461650B1 (en) | Preparation for supplementing a beverage and method for enriching a beverage in calcium and magnesium | |
CN102006868A (zh) | 用于缺铁性治疗的基于铁和锌的药物制剂 | |
KR20110110587A (ko) | 미네랄 조성물을 유효 성분으로 함유하는 항당뇨 활성을 갖는 당뇨 개선 및 예방용 약학적 조성물 | |
CN107375322B (zh) | 儿童及青少年型多种维生素矿物质泡腾片及其制备方法 | |
CN101253992A (zh) | 仙人掌果保健品 | |
KR101011038B1 (ko) | 홍삼 추출물 및 이를 함유한 홍삼 음료 | |
CN100512799C (zh) | 含铁锌钙多种维生素的泡腾片及其环形制剂与制备方法 | |
CN112675194A (zh) | 一种补钙组合物 | |
CN1985850B (zh) | 一种用于口服补充钙镁铁的药物组合物及制备方法和用途 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20200717 Address after: Biological high-tech Zone Industrial Park, Hubei city of Yichang Province, 443000 individual Road No. 519 Applicant after: Hubei Kang peptide Pharmaceutical Co.,Ltd. Address before: 314200 B 9, No. 988 Xinxing two road, Pinghu Economic Development Zone, Jiaxing, Zhejiang. Applicant before: ZHEJIANG XINNUO MEDICINE Co.,Ltd. |
|
TA01 | Transfer of patent application right | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20180608 |
|
RJ01 | Rejection of invention patent application after publication |